Informatie:
Fout:
ID
44096
Beschrijving
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00650078
Link
https://clinicaltrials.gov/show/NCT00650078
Trefwoorden
Versies (3)
- 02-10-18 02-10-18 -
- 02-10-18 02-10-18 -
- 20-09-21 20-09-21 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Rheumatoid Arthritis NCT00650078
Eligibility Rheumatoid Arthritis NCT00650078
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00650078
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Rheumatoid Arthritis
Item
documented history of ra in agreement with acr criteria
boolean
C0003873 (UMLS CUI [1])
DMARD Dose Stable Rheumatoid Arthritis
Item
dmard treatment for ra greater than or equal to 6 months, with a stable dose greater than or equal to 6 weeks prior to screening visit
boolean
C0242708 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003873 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0003873 (UMLS CUI [1,4])
Morning stiffness Duration
Item
duration of morning stiffness greater than or equal to 45 minutes
boolean
C0457086 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Swollen joint count
Item
greater than or equal to 4 swollen joints (out of 28)
boolean
C0451521 (UMLS CUI [1])
Tender joint count
Item
greater than or equal to 4 tender joints (out of 28)
boolean
C0451530 (UMLS CUI [1])
Disease Requirement Glucocorticoids
Item
suffering from another disease, which requires glucocorticoid treatment during the study period
boolean
C0012634 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0017710 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,2])
C0017710 (UMLS CUI [1,3])
Synovectomy
Item
synovectomy within 4 months prior to study start
boolean
C0185304 (UMLS CUI [1])
Glucocorticoids
Item
use of glucocorticoids:
boolean
C0017710 (UMLS CUI [1])
Glucocorticoids, Systemic
Item
continued use of systemic glucocorticoids within 4 weeks prior to screening visit
boolean
C3540777 (UMLS CUI [1])
Glucocorticoids Intermittent administration
Item
intermittent use of glucocorticoids within 2 weeks prior to screening visit.
boolean
C0017710 (UMLS CUI [1,1])
C0444735 (UMLS CUI [1,2])
C0444735 (UMLS CUI [1,2])
Joint injection
Item
joint injections within 6 weeks prior to screening visit
boolean
C0021488 (UMLS CUI [1])
Topical glucocorticoid To be stopped
Item
topical glucocorticoids must be stopped at screening visit
boolean
C0017712 (UMLS CUI [1,1])
C1272691 (UMLS CUI [1,2])
C1272691 (UMLS CUI [1,2])
Biological agents | Tumor necrosis factor alpha (TNF-) inhibitors
Item
use of biologicals such as: tumor necrosis factor α (tnfα) inhibitors and other compounds within 5 serum half lives prior to screening visit
boolean
C0005515 (UMLS CUI [1])
C3653350 (UMLS CUI [2])
C3653350 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])